Okadaic acid (OA) is a strong tumor promoter of mouse skin carcinogenesis and also a potent inhibitor of serine͞threonine protein phosphatases. OA induces various genetic alterations in cultured cells, such as diphtheriatoxin-resistance mutations, sister chromatid exchange, exclusion of exogenous transforming oncogenes, and gene amplification. The present study revealed that it caused minisatellite mutation (MSM) at a high frequency in NIH 3T3 cells, although no microsatellite mutation was found. Nine of 31 clones (29%) exhibited MSM after 6 days of OA treatment, as opposed to only 1 of 30 clones (3%) without OA exposure. Moreover, NIH 3T3 cells treated with OA acquired tumorigenicity in nude mice, giving rise to 7 tumors within 25 weeks in 20 sites where 3 ؋ 10 6 cells were injected. In contrast, the same numbers of untreated cells gave rise to only one tumor, and the tumor grew much slower. All of three OA-induced tumors examined manifested the MSM. The findings thus point to a molecular mechanism by which OA could function as a tumor promoter, and also the biological relevance of the induction of MSM in the tumorigenic process by OA.
Okadaic acid (OA) was originally isolated from the marine sponge Halichondria okadai (1) . It was subsequently shown to be a tumor promoter as potent as phorbol 12-tetradecanoate 13-acetate (12-O-tetradecanoylphorbol 13-acetate; TPA), although it does not activate protein kinase C. OA promotes mouse skin carcinogenesis in vivo (2) and transforms BALB͞ 3T3 mouse fibroblasts in vitro (3) after initiation with 7,12-dimethylbenz[a]anthracene and 3-methylcholanthrene, respectively. No initiating activities of OA were detected in a two-step model of carcinogenesis either in vitro or in vivo (2, 3) . Further, no mutations were induced in Salmonella typhimurium with or without rat liver S9 (postmitochondrial) metabolic activation system (4), and there has been no evidence that OA directly interacts with DNA. However, we have found that OA induces various genomic alterations in cultured cells, such as mutations endowing diphtheria-toxin resistance (4), sister chromatid exchange in the presence of bromodeoxyuridine (5) , and loss of exogenous transforming oncogenes (6) . OA also induces karyotype instability (7) and gene amplification under certain circumstances (8) . Although the molecular mechanisms underlying the genotoxic activity of OA have not been fully elucidated as yet, all the observed genetic alterations point to the induction of recombination events rather than introduction of point mutations. Because OA has another biological aspect as a potent inhibitor of serine͞ threonine protein phosphatases, especially types 2A and 4 (9, 10), alterations of the phosphorylation status of cellular proteins or other epigenetic events could be the molecular mechanisms involved.
A minisatellite (MS) (11) , also called a variable number of tandem repeats (VNTR) (12) , is an array of repeats of 5-100 nucleotides flanked by locus-specific sequences. MSs are dispersed throughout the entire genomes of all vertebrates (13) and are genetically stable sequences in somatic cells (14) , but they are known to be hot spots for meiotic recombination (15) . Recently, they have been demonstrated to be altered even in somatic cells when the cells are exposed to various chemical carcinogens and ultraviolet irradiation (16) , and they are also altered in various human and experimental animal tumors (17) (18) (19) (20) (21) .
In the present study, we investigated the molecular basis of genomic instability induced by OA, using MSs and microsatellites (MIs) as markers. MIs are composed of tandem repeats of simple sequences ranging from one to four nucleotides, and they are frequently altered in a variety of tumors as a consequence of mutations in mismatch repair genes (22) . Furthermore, we demonstrated that the induction of MS mutation (MSM) by OA can contribute to the acquisition of in vivo tumorigenicity.
MATERIALS AND METHODS
Chemicals, Cells, and Cell Culture Conditions. OA (molecular weight: 805.2) was purchased from Wako Pure Chemical (Osaka). The NIH 3T3 cell line, originally obtained from M. Wigler (Cold Spring Harbor Laboratory), was cultured as described (23) . To analyze the effects of OA on cell growth, aliquots of 10 4 cells in 1 ml of culture medium were seeded onto 30-mm plates, and OA with various amounts in 6 l of dimethyl sulfoxide as a solvent was added the next day. Cells were collected at appropriate times and cells were counted. Each experiment was carried out in triplicate, repeated twice.
Subcloning of NIH 3T3 Cells After OA Treatment. Aliquots of 2 ϫ 10 5 cells in 10 ml were seeded onto 100-mm culture plates 1 day before starting the experiments. The next day (day 1), OA was added to the medium at the concentration of 0 or 6 ng͞ml (7.5 nM). The cells were then cultured without changing the medium for 6 days and subjected to the subcloning procedure. Briefly, collected cells were suspended at a concentration of one per 400 l of culture medium without OA, and 100-l samples were replated in each well of 96-well plates and kept at 37°C for 2-3 weeks.
MS DNA Probe. The pPc-1 plasmid (24) , which contains 28 copies of 5Ј-GGGCA-3Ј sequence as a repetitive unit flanked with locus-specific sequences at both ends, was digested with EcoRI and HindIII, and the Pc-1 MS fragment 1.0 kb in length was purified by GlassMax (GIBCO͞BRL). The fragment was labeled with [␣-32 P]dCTP by using the Multiprime DNA labeling system (Amersham) as described earlier (25) .
MI PCR Primers. MI length alterations in 8 loci (D1Mit1, D1Jp1, D3Jp1, D5Jp5, D6Mit1, D9Jp2, Myc, and Int2) were analyzed by PCR-single strand length polymorphism (PCR-SSLP) as described previously (26) . The Mit-series primers were purchased from Research Genetics (Huntsville, AL). The sequences of the Jp-series primers applied are listed below: D1Jp1 (chromosome 1), 5Ј-AATCAGACACTACACCACAG-3Ј͞5Ј-TGTGGGAAGATGTGAACTTAC-3Ј; D3Jp1 (chromosome 3), 5Ј-GCTCCAGGGAATTTGATGCCT-3Ј͞5-ЈCGCCTCAT-TGACAAGTGCTAA-3Ј; D5Jp5 (chromosome 5) 5Ј-GATCT-GCTTATTACTTTCAGT-3Ј͞5Ј-CTCCACATGTGTGCTGT-GTGGTAC-3Ј; and D9Jp2 (chromosome 9), 5Ј-GATCTTGT-CTTCAACCTTTAATTC-3Ј͞5Ј-CCAAYACCACCCCA-TGATTTTGTA-3Ј.
DNA Fingerprint Analysis. DNA from NIH 3T3 cells or tumor tissues developing in nude mice was extracted as described previously (27) . Samples (2.5 g) of each DNA were digested with HaeIII, HinfI, or MboI, size-fractionated by electrophoresis in 1.0% agarose gels in 1 x TAE buffer (40 mM Tris⅐HCl͞40 mM acetic acid͞1 mM EDTA, pH 8.0) at 2 V͞cm for 20-24 h, then DNA was capillary blotted onto GeneScreenPlus nylon membranes (DuPont) by using the alkaline transfer method according to the manufacturer's protocol. After DNA was fixed by UV-crosslinking, prehybridization was performed in a solution of 4ϫ SSC (1ϫ SSC is 150 mM NaCl͞15 mM sodium citrate, pH 7.0) and 1% SDS at 65°C for 2 h, and subsequent hybridization was performed in the same buffer containing 25 ng of 32 P-labeled Pc-1 probe overnight. Membranes were then washed three times at 65°C in 1ϫ SSC͞0.5% SDS for 60 min and exposed to Kodak XAR film at room temperature for 1-7 days.
Assay for Tumorigenicity in Nude Mice. Aliquots of 10 5 cells were cultured and propagated in either the presence or the absence of 7.5 nM OA for 6 days and then for an additional 2 days with fresh medium without OA. On experimental day 9, the cells were collected, rinsed twice with phosphate-buffered saline (PBS), and resuspended in PBS. In groups of 10 mice, the shoulders on both sides of 5-week-old male BALB͞ cAJcl-nu mice (CLEA Japan, Osaka) were injected with 3 ϫ 10 6 cells per site subcutaneously.
Establishment of Tumor Cell Lines. Mice harboring tumors were sacrificed at appropriate times, and tumors were sterilely resected. Tumor tissues were minced and spread on 100-mm culture plates and allowed to sit for 10 min, and then 10 ml of culture medium was added to each plate. When cells had proliferated to near confluency, they were harvested and subjected to the subcloning procedure as described above. genicity was assayed by using whole groups of OA-treated cells as described in Materials and Methods, in which approximately 30% of the cells were expected to harbor MSM. Implantation of OA-treated cells at 20 sites gave rise to seven tumors, whereas untreated cells gave rise to only one tumor (data not shown). Three tumors from OA-treated cells, T1, T2, and T3, became visible by week 18, and then grew rapidly, doubling in volume within a week. The remainder of the tumors, including the one example derived from OA-untreated cells, appeared but grew much slower. MSM in Tumor Cells. To examine whether MSs were mutated in tumors developing in nude mice, DNA from tumors (T1 and T2) was subjected to fingerprint analysis with Pc-1 as a probe. Several MS band alterations were detected in both tumors (lanes 1 and 2 in Fig. 3A ) compared with the original NIH 3T3 cells (lane 5) as indicated by arrowheads. Further, a different fingerprint pattern was observed in host mouse DNA (lanes 3 and 4), which clearly represented the highly polymorphic feature of MS sequences in individual animals as described previously (13) . To eliminate the possibility of the DNA carry-over in tumor samples from host mice, we further analyzed primary tumor cell lines, TC1, TC2, and TC3, established from T1, T2, and T3, respectively (Fig. 3B) . All three tumor lines examined possessed bands shifted from the original NIH 3T3 (arrowhead), as detected in DNA from tumor tissues.
RESULTS

Induction of MSM in NIH 3T3
DISCUSSION
OA has been demonstrated to be a strong tumor promoter in two-step carcinogenesis experiments both in vivo (2) and in vitro (3), exerting its tumor-promoting activity through a molecular mechanism distinct from that of TPA (28) . However, efforts to explain this in terms of OA inhibition of protein phosphatases (8, 9) have not generated a complete understanding of the molecular mechanisms involved.
The present study clearly demonstrated that treatment with OA induces MSM in NIH 3T3 cells, the observed incidence of 29% of the total cell populations being significantly greater than in untreated cells (P Ͻ 0.01). We also demonstrated the acquisition of tumorigenicity by NIH 3T3 cells with OA treatment, and moreover, all three tumors analyzed manifested the MSM. These observations strongly support the idea that induction of MSM by OA is of essential relevance to its tumor-promoting activity. It would be more intriguing when it is clarified if TPA, which possesses biochemical activities distinct from OA as a potent tumor promoter, also induces MSM.
Several functions have been suggested for MSs, but their physiological relevance remains largely unclear. Some of the MSs, such as the insulin (INS)-VNTR (29), Ha-ras (HRAS1)-VNTR (30) , and immunoglobulin heavy chain (IGH)-VNTR (31), are located in either the 5Ј or the 3Ј regions of the genes or in introns, and they can exert modulatory activity. A rare allele of HRAS1-VNTR at the 3Ј end has been reported to have a significant association with common types of cancers, such as those in the breast, colorectum, and urinary bladder (32) . Ovarian cancer risk in BRCA1 mutant carriers is also modified by the HRAS1-VNTR (33) . INS-VNTR at the 5Ј end correlates with the expression level of the insulin gene (34) and has been implicated in susceptibility to insulin-dependent diabetes mellitus type 2 (IDDM2) (35) . The available evidence thus provides support for the attractive scenario that MSM may be involved in oncogenesis and other human disease (36) .
The molecular mechanisms responsible for the induction of MSM have yet to be elucidated, although it is known to occur in somatic cells treated with DNA-damaging agents, such as N-OH-2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (16) . There is, so far, no unequivocal evidence that OA directly interacts with DNA, but perturbation of the phosphorylation status of proteins through phosphatase inhibition could be a contributory cause. Among several plausible molecules, MSbinding proteins (Msbps) are strong candidates for involvement in MSM. Four types of Msbps have been identified so far and their biochemical properties have been partially characterized (37) (38) (39) . Msbp-4 has been shown to be phosphorylated in vitro, and its binding activity to MS sequence is known to be modulated by phosphorylation status (39) . Changes in the phosphorylation state of Msbps could lead to alteration in the recombination machinery and consequent induction of MSM.
In the case of human colon carcinogenesis, colorectal cancers without MI instability lose about 25% of alleles on average, while cancers with MI instability often lose none and are chromosomally relatively stable (40, 41) . It seems likely that only one type of genomic instability, MI instability or gross chromosomal changes, is sufficient for cancers to acquire selective growth advantage. Impairment of the mismatch repair system is considered to result mainly in the introduction of point mutations. With regard to this, the findings observed in the present study are clearly different and may be based on the distinct molecular mechanism from the mismatch repair system. Lengauer et al. (42) have recently published data indicating that colorectal tumors without MI instability exhibit a defect in chromosomal segregation, resulting in gains or losses in the genome. The molecular mechanisms involved in MSM observed in the present study are largely unknown; however, they could be partly implicated in the gross chromosomal changes seen in tumors without MI instability.
In conclusion, the present results provide a novel pointer to the molecular mechanisms of the tumor-promoting activity of OA, possibly through the inhibition of serine͞threonine protein phosphatase activity. 
